P25/30 SSEPs and Neurological Prognosis After Cardiac Arrest
P25/30 Somatosensory Evoked Potentials Are Associated With Neurological Prognosis of Comatose Survivors After Out of Hospital Cardiac Arrest
1 other identifier
observational
93
1 country
1
Brief Summary
Study Title: Early recorded P25/30 somatosensory evoked potentials are associated with neurologic prognosis of comatose survivors after out of hospital cardiac arrest. Design: Prospective, observational, non-interventional, study - prospective collection of data and interpretation. Analysis of the data and assessment of prognostic value of the P25/30 in critically ill patients post cardiac arrest. Study Aims: To be the first attempt to validate the prognostic potential of early recording \[between 24-36 hours post Return Of Spontaneous Circulation\] of P25/30 potentials in comatose survivors who are admitted to a British Intensive care unit after out of hospital cardiac arrest and who are not treated by hypothermic targeted temperature management. \[Validation of the prognostication significance of P25/30 Somatosensory Evoked Potentials in predicting neurologic outcome in comatose survivors post out of hospital cardiac arrest\]. Outcome Measures: Primary Endpoint: Neurologic outcome assessed by Cerebral Performance Category score at hospital discharge. Secondary endpoints: Mortality at hospital discharge and 28 days \[which occurs first\], comparison of prognostic benefit of N20 and P25/30 based multimodal prognostic models. Population: Comatose survivors, after out of hospital cardiac arrest, treated in Derriford Hospital ICU, Penrose and Pencarrow wards. Eligibility: Adults \[\>18 years old\], out of hospital cardiac arrest, comatose after Return Of Spontaneous Circulation, admission to intensive care Estimated Duration:36 months
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 8, 2018
CompletedFirst Submitted
Initial submission to the registry
November 19, 2018
CompletedFirst Posted
Study publicly available on registry
March 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 6, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 6, 2021
CompletedMay 6, 2023
April 1, 2022
3 years
November 19, 2018
May 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cerebral Performance Category [CPC] score
Neurological status of the participants assessed by the use of CPC score. CPC has 5 different scores describing the neurological outcome. CPC score 1: Full recovery or mild disability CPC score 2: Moderate Disability but independent in activities of daily living CPC score 3: Severe disability - Dependent in activities of daily living CPC score 4: persistent vegetative state CPC score 5: Death CPC scores 1 and 2 are considered positive \[good\] neurological outcomes, whereas scores 3-5 are considered negative \[poor\] neurological outcomes.
up to 30 days after cardiac arrest
Secondary Outcomes (2)
Mortality
up to 30 days after cardiac arrest
Correlation between P25/30 somatosensory evoked potentials presence and favourable prognosis
Up to 30 days after cardiac arrest
Eligibility Criteria
All adult \[\> 18 years old\] comatose survivors after non-trauma-related out of hospital cardiac arrest who are admitted to Derriford Hospital Intensive Care Unit.
You may qualify if:
- All adult comatose survivors after out of hospital cardiac arrest who are admitted to Derriford Hospital Intensive Care Unit \[Penrose and Pencarrow wards\]. The cause of cardiac arrest may be cardiac and/or non-cardiac or unknown at the time of enrolment.
- All patients must be comatose before intubation \[GCS equal or lower than 8\].
- All patients must be on one or more invasive organ support \[e.g. Endotracheal intubation and mechanical ventilation, vasopressor and/or inotropic support, Continuous Renal Replacement Therapy Sedated and/or on neuromuscular blocking agents\].
- All patients must be sedated before and during the time of SSEP recording. If clinically indicated, neuromuscular blocking agents may also be used.
- All patients must be on targeted temperature management as per Derriford ICU policy and protocol: For the first 24 hours after ICU admission, the target-temperature is 36°C with temperature control commencing within the first hour after critical care admission. For the next 48 hours the temperature of the patients will be maintained between 36-37°C. The aforementioned temperature targets are achieved with external cooling devices.
You may not qualify if:
- Non-comatose patients after ROSC
- Coma secondary to Intracranial and Intracerebral haemorrhage
- Patients with haemorrhagic shock
- Patients with severe neurologic disability \[CPC level higher than 2\] during the pre-cardiac arrest period
- Presence of active Demyelinating disease or past medical history of Demyelinating disease
- Trauma-related Cardiac arrest
- Previously or during the current admission diagnosed Spinal Cord and /or brain stem lesions
- Patients with Implantable defibrillator device \[incompatibility with SSEP recordings device\]
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals Plymouth NHS Trust
Plymouth, Devon, PL1 8DH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nikitas Nikitas, MD, PhD
University Hospitals Plymouth Department for Research Development and Innovation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2018
First Posted
March 20, 2019
Study Start
October 8, 2018
Primary Completion
October 6, 2021
Study Completion
October 6, 2021
Last Updated
May 6, 2023
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- Attached to ClinicalTrials.gov record
- Access Criteria
- ClinicalTrials.gov
IPD to be shared via ClinicalTrials.gov